FindTrial
Sign In

Effect of a 24 day inpatient integrative cancer care program on patients perception of illness and heart related measures

Impact of a 24 day inpatient Integrative Oncology protocol on the illness perception and heart rate variability in cancer patients - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/101086
Enrollment
40
Registered
2026-01-14
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C00-D49- Neoplasms

Interventions

Intervention1: Intergrative therapy protocol: Cancer patients will be treated with integrative therapy such as, High dose vitamin c, Oncothermia, Low dose chemotherapy, IV Nutritional therapy, Dietar

Sponsors

Mirakle Integrated Health Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Cancer patients taking atleast 24 days integrative therapies will be eligible for the study . Patients who are willing to participate and can give informed consent will be included

Exclusion criteria

Exclusion criteria: Any patients who is unable to give informed consent due to cognitive impairment will not be included in the study. Patients those who cant complete 24 days treatment will also be excluded

Design outcomes

Primary

MeasureTime frame
Brief Illness Perception Questionnaire (BIPQ) total scoreTimepoint: Baseline ( At the time of treatment ) After 24 days of treatment—

Secondary

MeasureTime frame
Change in HRV parameters ( SDNN, RMSSD, HF/LF ratio) change in overall quality of life ( EORTC QLQ-C30) Change in disease prognosis ( CPS )Timepoint: Baseline After 24 days of treatment—

Countries

India

Contacts

Public ContactDr Pradeep M K Nair

Mirakle Integrated Health Centre

research@mirakleihc.com8667483682

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026